OBJECTIVES: Our aim was to determine the frequency of genomic imbalances in neonates with birth defects by using targeted array-based comparative genomic hybridization, also known as chromosomal microarray analysis. METHODS: Between March 2006 and September 2007, 638 neonates with various birth defects were referred for chromosomal microarray analysis. Three consecutive chromosomal microarray analysis versions were used: bacterial artificial chromosome-based versions V5 and V6 and bacterial artificial chromosome emulated oligonucleotide-based version V6 Oligo. Each version had targeted but increasingly extensive genomic coverage and interrogated>150 disease loci with enhanced coverage in genomic rearrangement-prone pericentromeric and subtelomeric regions. RESULTS: Overall, 109 (17.1%) patients were identified with clinically significant abnormalities with detection rates of 13.7%, 16.6%, and 19.9% on V5, V6, and V6 Oligo, respectively. The majority of these abnormalities would not be defined by using karyotype analysis. The clinically significant detection rates by use of chromosomal microarray analysis for various clinical indications were 66.7% for "possible chromosomal abnormality"+/-"others" (other clinical indications), 33.3% for ambiguous genitalia+/-others, 27.1% for dysmorphic features+multiple congenital anomalies+/-others, 24.6% for dysmorphic features+/-others, 21.8% for congenital heart disease+/-others, 17.9% for multiple congenital anomalies+/-others, and 9.5% for the patients referred for others that were different from the groups defined. In all, 16 (2.5%) patients had chromosomal aneuploidies, and 81 (12.7%) patients had segmental aneusomies including common microdeletion or microduplication syndromes and other genomic disorders. Chromosomal mosaicism was found in 12 (1.9%) neonates. CONCLUSIONS: Chromosomal microarray analysis is a valuable clinical diagnostic tool that allows precise and rapid identification of genomic imbalances and mosaic abnormalities as the cause of birth defects in neonates. Chromosomal microarray analysis allows for timely molecular diagnoses and detects many more clinically relevant genomic abnormalities than conventional cytogenetic studies, enabling more informed decision-making and management and appropriate assessment of recurrence risk.
OBJECTIVES: Our aim was to determine the frequency of genomic imbalances in neonates with birth defects by using targeted array-based comparative genomic hybridization, also known as chromosomal microarray analysis. METHODS: Between March 2006 and September 2007, 638 neonates with various birth defects were referred for chromosomal microarray analysis. Three consecutive chromosomal microarray analysis versions were used: bacterial artificial chromosome-based versions V5 and V6 and bacterial artificial chromosome emulated oligonucleotide-based version V6 Oligo. Each version had targeted but increasingly extensive genomic coverage and interrogated>150 disease loci with enhanced coverage in genomic rearrangement-prone pericentromeric and subtelomeric regions. RESULTS: Overall, 109 (17.1%) patients were identified with clinically significant abnormalities with detection rates of 13.7%, 16.6%, and 19.9% on V5, V6, and V6 Oligo, respectively. The majority of these abnormalities would not be defined by using karyotype analysis. The clinically significant detection rates by use of chromosomal microarray analysis for various clinical indications were 66.7% for "possible chromosomal abnormality"+/-"others" (other clinical indications), 33.3% for ambiguous genitalia+/-others, 27.1% for dysmorphic features+multiple congenital anomalies+/-others, 24.6% for dysmorphic features+/-others, 21.8% for congenital heart disease+/-others, 17.9% for multiple congenital anomalies+/-others, and 9.5% for the patients referred for others that were different from the groups defined. In all, 16 (2.5%) patients had chromosomal aneuploidies, and 81 (12.7%) patients had segmental aneusomies including common microdeletion or microduplication syndromes and other genomic disorders. Chromosomal mosaicism was found in 12 (1.9%) neonates. CONCLUSIONS: Chromosomal microarray analysis is a valuable clinical diagnostic tool that allows precise and rapid identification of genomic imbalances and mosaic abnormalities as the cause of birth defects in neonates. Chromosomal microarray analysis allows for timely molecular diagnoses and detects many more clinically relevant genomic abnormalities than conventional cytogenetic studies, enabling more informed decision-making and management and appropriate assessment of recurrence risk.
Authors: S J White; L E L M Vissers; A Geurts van Kessel; R X de Menezes; E Kalay; A E Lehesjoki; P C Giordano; E van de Vosse; M H Breuning; H G Brunner; J T den Dunnen; J A Veltman Journal: Cytogenet Genome Res Date: 2007 Impact factor: 1.636
Authors: Sau W Cheung; Chad A Shaw; Daryl A Scott; Ankita Patel; Trilochan Sahoo; Carlos A Bacino; Amber Pursley; Jiangzhen Li; Robert Erickson; Andrea L Gropman; David T Miller; Margretta R Seashore; Anne M Summers; Pawel Stankiewicz; A Craig Chinault; James R Lupski; Arthur L Beaudet; V Reid Sutton Journal: Am J Med Genet A Date: 2007-08-01 Impact factor: 2.802
Authors: Shay Ben-Shachar; Zhishuo Ou; Chad A Shaw; John W Belmont; Millan S Patel; Marybeth Hummel; Stephen Amato; Nicole Tartaglia; Jonathan Berg; V Reid Sutton; Seema R Lalani; A Craig Chinault; Sau W Cheung; James R Lupski; Ankita Patel Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Anne W Higgins; Fowzan S Alkuraya; Amy F Bosco; Kerry K Brown; Gail A P Bruns; Diana J Donovan; Robert Eisenman; Yanli Fan; Chantal G Farra; Heather L Ferguson; James F Gusella; David J Harris; Steven R Herrick; Chantal Kelly; Hyung-Goo Kim; Shotaro Kishikawa; Bruce R Korf; Shashikant Kulkarni; Eric Lally; Natalia T Leach; Emma Lemyre; Janine Lewis; Azra H Ligon; Weining Lu; Richard L Maas; Marcy E MacDonald; Steven D P Moore; Roxanna E Peters; Bradley J Quade; Fabiola Quintero-Rivera; Irfan Saadi; Yiping Shen; Jay Shendure; Robin E Williamson; Cynthia C Morton Journal: Am J Hum Genet Date: 2008-03 Impact factor: 11.025
Authors: Zhishuo Ou; Jonathan S Berg; Hagith Yonath; Victoria B Enciso; David T Miller; Jonathan Picker; Tiffanee Lenzi; Catherine E Keegan; Vernon R Sutton; John Belmont; A Craig Chinault; James R Lupski; Sau Wai Cheung; Elizabeth Roeder; Ankita Patel Journal: Genet Med Date: 2008-04 Impact factor: 8.822
Authors: Zhishuo Ou; Sung-Hae L Kang; Chad A Shaw; Condie E Carmack; Lisa D White; Ankita Patel; Arthur L Beaudet; Sau Wai Cheung; A Craig Chinault Journal: Genet Med Date: 2008-04 Impact factor: 8.822
Authors: Jonathan S Berg; Nicola Brunetti-Pierri; Sarika U Peters; Sung-Hae L Kang; Chin-to Fong; Jessica Salamone; Debra Freedenberg; Vickie L Hannig; Lisa Albers Prock; David T Miller; Peter Raffalli; David J Harris; Robert P Erickson; Christopher Cunniff; Gary D Clark; Maria A Blazo; Daniel A Peiffer; Kevin L Gunderson; Trilochan Sahoo; Ankita Patel; James R Lupski; Arthur L Beaudet; Sau Wai Cheung Journal: Genet Med Date: 2007-07 Impact factor: 8.822
Authors: M De Gregori; R Ciccone; P Magini; T Pramparo; S Gimelli; J Messa; F Novara; A Vetro; E Rossi; P Maraschio; M C Bonaglia; C Anichini; G B Ferrero; M Silengo; E Fazzi; A Zatterale; R Fischetto; C Previderé; S Belli; A Turci; G Calabrese; F Bernardi; E Meneghelli; M Riegel; M Rocchi; S Guerneri; F Lalatta; L Zelante; C Romano; M Fichera; T Mattina; G Arrigo; M Zollino; S Giglio; F Lonardo; A Bonfante; A Ferlini; F Cifuentes; H Van Esch; L Backx; A Schinzel; J R Vermeesch; O Zuffardi Journal: J Med Genet Date: 2007-08-31 Impact factor: 6.318
Authors: Philip M Boone; Carlos A Bacino; Chad A Shaw; Patricia A Eng; Patricia M Hixson; Amber N Pursley; Sung-Hae L Kang; Yaping Yang; Joanna Wiszniewska; Beata A Nowakowska; Daniela del Gaudio; Zhilian Xia; Gayle Simpson-Patel; LaDonna L Immken; James B Gibson; Anne C-H Tsai; Jennifer A Bowers; Tyler E Reimschisel; Christian P Schaaf; Lorraine Potocki; Fernando Scaglia; Tomasz Gambin; Maciej Sykulski; Magdalena Bartnik; Katarzyna Derwinska; Barbara Wisniowiecka-Kowalnik; Seema R Lalani; Frank J Probst; Weimin Bi; Arthur L Beaudet; Ankita Patel; James R Lupski; Sau Wai Cheung; Pawel Stankiewicz Journal: Hum Mutat Date: 2010-11-02 Impact factor: 4.878
Authors: Pengfei Liu; Ayelet Erez; Sandesh C Sreenath Nagamani; Weimin Bi; Claudia M B Carvalho; Alexandra D Simmons; Joanna Wiszniewska; Ping Fang; Patricia A Eng; M Lance Cooper; V Reid Sutton; Elizabeth R Roeder; John B Bodensteiner; Mauricio R Delgado; Siddharth K Prakash; John W Belmont; Pawel Stankiewicz; Jonathan S Berg; Marwan Shinawi; Ankita Patel; Sau Wai Cheung; James R Lupski Journal: Hum Mol Genet Date: 2011-02-25 Impact factor: 6.150
Authors: Ibtessam R Hussein; Rima S Bader; Adeel G Chaudhary; Randa Bassiouni; Maha Alquaiti; Fai Ashgan; Hans-Juergen Schulten; Mohammad H Al Qahtani Journal: Pediatr Cardiol Date: 2018-03-14 Impact factor: 1.655
Authors: Alexander G Bassuk; Lakshmi B Muthuswamy; Riley Boland; Tiffany L Smith; Alissa M Hulstrand; Hope Northrup; Matthew Hakeman; Jason M Dierdorff; Christina K Yung; Abby Long; Rachel B Brouillette; Kit Sing Au; Christina Gurnett; Douglas W Houston; Robert A Cornell; J Robert Manak Journal: Hum Mol Genet Date: 2012-12-07 Impact factor: 6.150